178 related articles for article (PubMed ID: 29673740)
1. Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.
Averbach S; Silverberg MJ; Leyden W; Smith-McCune K; Raine-Bennett T; Sawaya GF
Contraception; 2018 Apr; ():. PubMed ID: 29673740
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study.
Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF
Lancet Child Adolesc Health; 2018 Oct; 2(10):707-714. PubMed ID: 30236379
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.
Loopik DL; IntHout J; Melchers WJG; Massuger LFAG; Bekkers RLM; Siebers AG
Eur J Cancer; 2020 Jan; 124():102-109. PubMed ID: 31760309
[TBL] [Abstract][Full Text] [Related]
5. Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark.
Skorstengaard M; Lynge E; Napolitano G; Blaakær J; Bor P
Hum Reprod; 2021 Jun; 36(7):1796-1807. PubMed ID: 33974685
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
Castle PE; Walker JL; Schiffman M; Wheeler CM
Int J Cancer; 2005 Dec; 117(6):1007-12. PubMed ID: 15986443
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology associated with levonorgestrel contraception.
Misra JS; Engineer AD; Tandon P
Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
[TBL] [Abstract][Full Text] [Related]
10. Cervical carcinogenesis and contraception.
Misra JS; Engineer AD; Das K; Tandon P
Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
12. Invasive cervical cancer and intrauterine device use.
Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
[TBL] [Abstract][Full Text] [Related]
13. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
14. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
15. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
16. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
17. Current use of an intrauterine device and risk of tubal pregnancy.
Rossing MA; Daling JR; Voigt LF; Stergachis AS; Weiss NS
Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989
[TBL] [Abstract][Full Text] [Related]
18. Effects of various IUDs on the composition of cervical mucus.
Jonsson B; Landgren BM; Eneroth P
Contraception; 1991 May; 43(5):447-58. PubMed ID: 1914458
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
